Oct 01, 2018
Nektar Therapeutics Strengthens Board of Directors with Appointment of Veteran Biotechnology Executive Karin Eastham
Aug 01, 2018
Nektar to Announce Financial Results for the Second Quarter 2018 on Wednesday, August 8, 2018, After Close of U.S.-Based Financial Markets
Jun 05, 2018
Nektar to Webcast Presentation at the Jefferies 2018 Healthcare Conference in New York
May 03, 2018
Nektar to Announce Financial Results for the First Quarter 2018 on Thursday, May 10, 2018, After Close of U.S.-Based Financial Markets
Mar 07, 2018
Nektar to Webcast Presentation at the Cowen and Company 38th Annual Health Care Conference in Boston
Feb 21, 2018
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2017 on Thursday, March 1, 2018, After Close of U.S.-Based Financial Markets
Jan 03, 2018
Nektar Therapeutics' President and CEO, Howard Robin, To Present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
Nov 27, 2017
Nektar to Webcast Presentation at the Piper Jaffray 29th Annual Healthcare Conference in New York City
Nov 10, 2017
Nektar to Webcast Presentation at Jefferies 2017 London Healthcare Conference
Oct 31, 2017
Nektar to Announce Financial Results for the Third Quarter of 2017 on Tuesday, November 7, 2017, After Close of U.S.-Based Financial Markets
Sep 06, 2017
Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2017 Morgan Stanley Global Healthcare Conference in New York City
Aug 02, 2017
Nektar to Announce Financial Results for the Second Quarter of 2017 on Tuesday, August 8, 2017, After Close of U.S.-Based Financial Markets
Jun 06, 2017
Nektar to Webcast Presentation at Jefferies 2017 Global Healthcare Conference in New York City